Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study — Micros

Localized Osteosarcoma Clinical Trial

Official title:
Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study

Status Recruiting

Clinical Trial Summary

International, multicenter retrospecitve biological study

Clinical Trial Description

International, multicenter retrospecitve biological study that will analyze the tumor micro environment in biological archival samples of patients, who were treated with mifamurtide according the protocols for primary localized osteosarcoma (ISG-OS2 and GEIS-33) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03737435
Study type	Observational
Source	Istituto Ortopedico Rizzoli
Contact	Emanuela Palmerini, MD
Phone	+390516966199
Email	emanuela.palmerini@ior.it
Status	Recruiting
Phase
Start date	December 12, 2018
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01807052` - Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas	N/A
Completed	`NCT00134030` - Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Phase 3
Suspended	`NCT05691478` - A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	Phase 2/Phase 3
Recruiting	`NCT04890067` - Observational Study in Localized Osteosarcoma
Completed	`NCT01374672` - Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma	N/A
Completed	`NCT00954473` - Study of Blood Samples From Patients With Osteosarcoma	N/A
Not yet recruiting	`NCT05683197` - A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	Phase 2/Phase 3
Completed	`NCT01190943` - DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma